These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 13132098)

  • 1. [Four years of BCG vaccination in an enterprise; some practical notes, remarks and suggestions].
    POULAIN P
    Med Usine Rev Hyg Ind Mal Prof; 1953 Dec; 15(10):536-41. PubMed ID: 13132098
    [No Abstract]   [Full Text] [Related]  

  • 2. [Four years of B.C.G. vaccination: some practical notes, remarks and suggestions].
    POULAIN P
    Rev Hyg Med Soc; 1953; 1(7):681-6. PubMed ID: 13135036
    [No Abstract]   [Full Text] [Related]  

  • 3. [BCG vaccine coverage in private medical practice: First data in children below two years old, seven months after the end of compulsory vaccination in France].
    Guthmann JP; de La Rocque F; Boucherat M; van Cauteren D; Fonteneau L; Lécuyer A; Cohen R; Lévy-Bruhl D
    Arch Pediatr; 2009 May; 16(5):489-95. PubMed ID: 19304464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abortive reaction and time of scar formation after BCG vaccination.
    Faridi MM; Krishnamurthy S
    Vaccine; 2008 Jan; 26(3):289-90. PubMed ID: 18093699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Contemporary status of BCG vaccine in the world and in Serbia].
    Pesut D
    Med Pregl; 2004; 57 Suppl 1():37-40. PubMed ID: 15686220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Notes on indiscriminate BCG vaccination; refutation of an article].
    DE ASSIS A
    Hospital (Rio J); 1959 Jun; 55(6):821-34. PubMed ID: 13672534
    [No Abstract]   [Full Text] [Related]  

  • 8. [Severe adverse reactions after vaccination with Japanese BCG vaccine: a review].
    Toida I; Nakata S
    Kekkaku; 2007 Nov; 82(11):809-24. PubMed ID: 18078106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of Bacillus Calmette Guerin (BCG) vaccination in the prevention of leprosy: a population-based case-control study in Yavatmal District, India.
    Zodpey SP; Ambadekar NN; Thakur A
    Public Health; 2005 Mar; 119(3):209-16. PubMed ID: 15661132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical inquiries. How should we manage a patient with a positive PPD and prior BCG vaccination?
    Rowland K; Guthmann R; Jamieson B; Malloy D
    J Fam Pract; 2006 Aug; 55(8):718-20. PubMed ID: 16882448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Community cohort study of Cryptosporidium parvum infections: sex-differential incidences associated with BCG and diphtheria-tetanus-pertussis vaccinations.
    Valentiner-Branth P; Perch M; Nielsen J; Steinsland H; Garly ML; Fischer TK; Sommerfelt H; Mølbak K; Aaby P
    Vaccine; 2007 Mar; 25(14):2733-41. PubMed ID: 16513227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of the leprosy component of the Brazilian BCG revaccination trial for assessing BCG effectiveness against leprosy in school children.
    Cunha SS; Dourado I; Barreto ML; Alexander N; Pereira SM; Ichihara Y; Pereira ES; Pedrosa V; Maroja F; Ribas C; Rodrigues LC
    Int J Lepr Other Mycobact Dis; 2004 Mar; 72(1):8-15. PubMed ID: 15217320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consensus statement on the revised World Health Organization recommendations for BCG vaccination in HIV-infected infants.
    Hesseling AC; Cotton MF; Fordham von Reyn C; Graham SM; Gie RP; Hussey GD
    Int J Tuberc Lung Dis; 2008 Dec; 12(12):1376-9. PubMed ID: 19017445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is the prevalence of wheeze in children altered by neonatal BCG vaccination?
    Linehan MF; Frank TL; Hazell ML; Francis HC; Morris JA; Baxter DN; Niven RM
    J Allergy Clin Immunol; 2007 May; 119(5):1079-85. PubMed ID: 17379292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors influencing the protective efficacy of a BCG homologous prime-boost vaccination regime against tuberculosis.
    Griffin JF; Mackintosh CG; Rodgers CR
    Vaccine; 2006 Feb; 24(6):835-45. PubMed ID: 16098638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination of neonatal calves with Mycobacterium bovis BCG induces protection against intranasal challenge with virulent M. bovis.
    Hope JC; Thom ML; Villarreal-Ramos B; Vordermeier HM; Hewinson RG; Howard CJ
    Clin Exp Immunol; 2005 Jan; 139(1):48-56. PubMed ID: 15606613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of Bacillus Calmette Guerin (BCG) vaccination in prevention of pulmonary tuberculosis.
    Zodpey SP; Maldhure BR; Kulkarni SW
    J Commun Dis; 2004 Sep; 36(3):159-65. PubMed ID: 16509251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [BCG vaccination against tuberculosis in the health system].
    Bugiani M; Besozzi G; Codecasa L; Migliori GB; Fiorentini F;
    Med Lav; 2005; 96(2):178-80. PubMed ID: 16001519
    [No Abstract]   [Full Text] [Related]  

  • 19. [Nature and practical application of BCG vaccination against tuberculosis].
    HAEFLIGER E
    Praxis; 1954 May; 43(21):453-7. PubMed ID: 13185926
    [No Abstract]   [Full Text] [Related]  

  • 20. [Various staid practical problems; BCG vaccination].
    MANDE R
    Rev Prat; 1957 Jan; 7(3):285-303. PubMed ID: 13421281
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.